Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patientsJapanese journal of clinical oncology, 2018-07, Vol.48 (7), p.609-618 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy069 ;PMID: 29767751Full text available |
|
2 |
Material Type: Article
|
Adult height in relation to the risk of colorectal cancer among the Japanese population: an evaluation based on systematic review and meta-analysisJapanese journal of clinical oncology, 2022-04, Vol.52 (4), p.322-330 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2021 ;The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyab203 ;PMID: 34969070Full text available |
|
3 |
Material Type: Article
|
Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 studyJapanese journal of clinical oncology, 2018-11, Vol.48 (11), p.1012-1021 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2018 ;The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy129 ;PMID: 30371895Full text available |
|
4 |
Material Type: Article
|
A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRCJapanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1088-1095 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy136 ;PMID: 30257010Full text available |
|
5 |
Material Type: Article
|
Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subsetJapanese journal of clinical oncology, 2018-04, Vol.48 (4), p.367-375 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. 2018 ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy016 ;PMID: 29474558Full text available |
|
6 |
Material Type: Article
|
The investigation study using a questionnaire about the employment of Japanese breast cancer patientsJapanese journal of clinical oncology, 2018-08, Vol.48 (8), p.712-717 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy088 ;PMID: 29939297Full text available |
|
7 |
Material Type: Article
|
A multicenter Phase II study of sorafenib in Japanese patients with advanced hepatocellular carcinoma and Child Pugh A and B classJapanese journal of clinical oncology, 2018-04, Vol.48 (4), p.317-321 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy010 ;PMID: 29474553Full text available |
|
8 |
Material Type: Article
|
Safety and tolerability of selumetinib as a monotherapy, or in combination with docetaxel as second-line therapy, in Japanese patients with advanced solid malignancies or non-small cell lung cancerJapanese journal of clinical oncology, 2018-01, Vol.48 (1), p.31-42 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2017 ;The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx144 ;PMID: 29136201Full text available |
|
9 |
Material Type: Article
|
Loss of CD15 expression in clear cell renal cell carcinoma is correlated with worse prognosis in Chinese patientsJapanese journal of clinical oncology, 2017-12, Vol.47 (12), p.1182-1188 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx139 ;PMID: 29036563Full text available |
|
10 |
Material Type: Article
|
Prevalence and molecular characteristics of defective mismatch repair epithelial ovarian cancer in a Japanese hospital-based populationJapanese journal of clinical oncology, 2018-08, Vol.48 (8), p.728-735 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy081 ;PMID: 29889250Full text available |
|
11 |
Material Type: Article
|
Efficacy and safety of a 3-month dosing regimen of degarelix in Japanese patients with prostate cancer: a phase II maintenance-dose-finding studyJapanese journal of clinical oncology, 2017-05, Vol.47 (5), p.438-446 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx011 ;PMID: 28334771Full text available |
|
12 |
Material Type: Article
|
First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trialJapanese journal of clinical oncology, 2017-05, Vol.47 (5), p.385-392 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx001 ;PMID: 28158579Full text available |
|
13 |
Material Type: Article
|
Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subsetJapanese journal of clinical oncology, 2017-07, Vol.47 (7), p.618-624 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyx045 ;PMID: 28369553Full text available |
|
14 |
Material Type: Article
|
Phase 1 study of ombrabulin in combination with docetaxel and cisplatin in Japanese patients with advanced solid tumorsJapanese journal of clinical oncology, 2018-04, Vol.48 (4), p.322-328 [Peer Reviewed Journal]ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy026 ;PMID: 29514256Full text available |
|
15 |
Material Type: Article
|
Trends in the quality assurance process indicators for Japanese colorectal cancer screening during 2003–13Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.329-334 [Peer Reviewed Journal]The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2018 ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyy022 ;PMID: 29506049Full text available |
|
16 |
Material Type: Article
|
Safety, efficacy and pharmacokinetics of humanized anti-CD52 monoclonal antibody alemtuzumab in Japanese patients with relapsed or refractory B-cell chronic lymphocytic leukemiaJapanese journal of clinical oncology, 2017-01, Vol.47 (1), p.54-60 [Peer Reviewed Journal]The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw146 ;PMID: 28122892Full text available |
|
17 |
Material Type: Article
|
Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trialJapanese journal of clinical oncology, 2017-06, Vol.47 (6), p.551-559 [Peer Reviewed Journal]The Author 2017. Published by Oxford University Press. ;The Author 2017. Published by Oxford University Press. 2017 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyw194 ;PMID: 28334974Full text available |
|
18 |
Material Type: Article
|
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062Japanese journal of clinical oncology, 2023-03, Vol.53 (3), p.221-229 [Peer Reviewed Journal]The Author(s) 2022. Published by Oxford University Press. 2022 ;The Author(s) 2022. Published by Oxford University Press. ;ISSN: 1465-3621 ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyac188 ;PMID: 36533429Full text available |
|
19 |
Material Type: Article
|
An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013Japanese journal of clinical oncology, 2015-04, Vol.45 (4), p.390-401 [Peer Reviewed Journal]The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0368-2811 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyv002 ;PMID: 25637502Full text available |
|
20 |
Material Type: Article
|
Prognostic awareness in Japanese patients with advanced cancer: a follow-up cohort studyJapanese journal of clinical oncology, 2023-04, Vol.53 (5), p.410-418 [Peer Reviewed Journal]The Author(s) 2023. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1465-3621 ;EISSN: 1465-3621 ;DOI: 10.1093/jjco/hyad002 ;PMID: 36647604Full text available |